HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influence of geranylgeranylacetone on the expression of HSP70 in retina of rats with chronic IOP elevation.

AbstractAIM:
To study the effects of geranylgeranylacetone (GGA) on the expression of heat shock protein70 (HSP70) on retinal ganglion cells (RGC) in rats with chronic intraocular pressure (IOP) elevation.
METHODS:
Seventy Wistars were divided into blank control group (10 rats), chronic hypertension group (30 rats) and GGA group (30 rats). Chronic hypertension was created by cauterizing the superficial scleral veins. 800mg/kg/d GGA was given by oral daily after cauterization. Immunohistochemistry was used respectively to observe the changes of expression of HSP70 in the model rats and GGA interference rats at different time points during the course of chronic IOP elevation.
RESULTS:
The successful model was identified as the IOP over 40% of normal rats. The retinal thickness was significantly reduced in model group and model+GGA group compared with normal rats from 21 days through 28 days after cauterization (P<0.05), and that of model rats was obviously decreased in comparison with model+GGA rats (P<0.05). The number of ganglion cells was significantly decreased in model rats and model+GGA rats compared with normal rats from 21 days and 28 days. The stronger expression intensity (IOD) value was seen for HSP70 in the model+GGA rats by immunochemistry (P<0.01).
CONCLUSION:
Systemic administration of GGA protects retina from chronic IOP elevation by regulating the expression of HSP70.
AuthorsZhi-Li Liu, Ying-Rong Wang, Qian Sha, Qing-Zhu Nie
JournalInternational journal of ophthalmology (Int J Ophthalmol) Vol. 3 Issue 1 Pg. 28-31 ( 2010) ISSN: 2222-3959 [Print] China
PMID22553512 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: